 | CytoSorbents Announces Virtual Annual Meeting - PRNewswire
www.prnewswire.com - May 27 at 7:16 PM |
 | CytoSorbents Announces Virtual Annual Meeting
finance.yahoo.com - May 27 at 2:14 PM |
| CTSO: Q1 2020: CTSO Nabs FDA breakthrough designation and European approval for ticagrelor removal, Q1 Product revenue sets new record, Moving PT to $15/share
finance.yahoo.com - May 19 at 1:28 PM |
 | Cytosorbents Corp (NASDAQ:CTSO) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - May 19 at 6:48 AM |
 | BRIEF-Cytosorb Approved & Available In European Union- Cytosorbents - Reuters
www.reuters.com - May 13 at 3:51 AM |
| CytoSorb® is EU Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic Surgery - PRNewswire
www.prnewswire.com - May 12 at 5:50 PM |
 | CytoSorb OK'd in Europe to remove rivaroxaban during cardiothoracic surgery
seekingalpha.com - May 12 at 7:32 AM |
| CytoSorb® is E.U. Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic Surgery
finance.yahoo.com - May 12 at 7:32 AM |
|
| $9.08 Million in Sales Expected for Cytosorbents Corp (NASDAQ:CTSO) This Quarter
www.americanbankingnews.com - May 12 at 1:36 AM |
| Analysts Anticipate Cytosorbents Corp (NASDAQ:CTSO) Will Announce Earnings of -$0.09 Per Share
www.americanbankingnews.com - May 11 at 12:12 AM |
| The Charts of Cytosorbents Suggest We Might See Further Gains Ahead
finance.yahoo.com - May 8 at 5:00 PM |
| B. Riley Weighs in on Cytosorbents Corp's Q2 2020 Earnings (NASDAQ:CTSO)
www.americanbankingnews.com - May 8 at 1:00 PM |
| Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at Maxim Group
www.americanbankingnews.com - May 8 at 6:22 AM |
| B. Riley Analysts Boost Earnings Estimates for Cytosorbents Corp (NASDAQ:CTSO)
www.americanbankingnews.com - May 7 at 6:31 PM |
 | Cytosorbents Corp (CTSO) Q1 2020 Earnings Call Transcript - Motley Fool
www.fool.com - May 7 at 4:28 AM |
| Cytosorbents Corp (CTSO) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 7 at 4:28 AM |
| Cytosorbents (NASDAQ:CTSO) Price Target Increased to $16.00 by Analysts at B. Riley
www.americanbankingnews.com - May 7 at 12:30 AM |
| Cytosorbents (NASDAQ:CTSO) PT Raised to $14.00
www.americanbankingnews.com - May 6 at 11:58 PM |
| Cytosorbents (NASDAQ:CTSO) Announces Earnings Results, Beats Expectations By $0.04 EPS
www.americanbankingnews.com - May 6 at 8:48 PM |
| Edited Transcript of CTSO.OQ earnings conference call or presentation 5-May-20 8:45pm GMT - Yahoo Finance
finance.yahoo.com - May 6 at 1:02 PM |
| Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 6 at 5:01 AM |
| BRIEF-Cytosorbents Reports Qtrly Loss Per Share Of $0.10 - Reuters
www.reuters.com - May 5 at 11:10 PM |
| CytoSorbents Reports First Quarter 2020 Financial and Operational Results - PRNewswire
www.prnewswire.com - May 5 at 4:21 PM |
| CytoSorbents Reports First Quarter 2020 Financial and Operational Results
finance.yahoo.com - May 5 at 4:21 PM |
| BRIEF-Cytosorbents Promotes Vincent J. Capponi To President - Reuters
www.reuters.com - May 4 at 9:48 AM |
| CytoSorbents Promotes Vincent J. Capponi to President
finance.yahoo.com - May 4 at 9:48 AM |
| CytoSorbents secures $1.1M in new funding via NJ program - Seeking Alpha
seekingalpha.com - April 29 at 8:01 AM |
| Cytosorbents: COVID-19 Has Presented A Bullish Opportunity - Seeking Alpha
seekingalpha.com - April 29 at 8:01 AM |
| CytoSorbents to Report Q1 2020 Operating and Financial Results - PRNewswire
www.prnewswire.com - April 28 at 4:55 PM |
| CytoSorbents to Report Q1 2020 Operating and Financial Results
finance.yahoo.com - April 28 at 11:55 AM |
|
| New medical chief at CytoSorbents - Seeking Alpha
seekingalpha.com - April 27 at 10:14 AM |
| Cytosorbents Appoints Dr. Efthymios N. Deliargyris, M.D., As Chief Medical Officer
finance.yahoo.com - April 27 at 10:14 AM |
 | Form 8-K Cytosorbents Corp For: Apr 20 - StreetInsider.com
www.streetinsider.com - April 20 at 11:53 PM |
| BRIEF-Cytosorbents Entered Into Into Amendment To Open Market Sale Agreement With Jefferies Relating To Sale Of Shares Of Common Stock - Reuters
www.reuters.com - April 20 at 6:52 PM |
| Cytosorbents (CTSO) Announces FDA Grants Breakthrough Designation to CytoSorb for Removal of Ticagrelor During Cardiopulmonary Bypass in Emergent and Urgent Cardiothoracic Surgery - StreetInsider.com
www.streetinsider.com - April 20 at 8:50 AM |
| CytoSorbents up 7% premarket on Breakthrough Designation tag for CytoSorb - Seeking Alpha
seekingalpha.com - April 20 at 8:50 AM |
| Development Update: U.S. FDA Grants Breakthrough Designation to CytoSorb for Removal of Ticagrelor During Cardiopulmonary Bypass in Emergent and Urgent Cardiothoracic Surgery
finance.yahoo.com - April 20 at 8:50 AM |
 | Coronavirus Treatment Could Be in Hospitals 'Next Week,' Cytosorbents CEO Says - TheStreet
www.thestreet.com - April 16 at 5:46 PM |
 | Cramer's lightning round: Amarin has been 'too much of a dice roll' - CNBC
www.cnbc.com - April 15 at 8:12 PM |
| BRIEF-Cytosorbents-New Study Suggests Cytosorb Improves Clinical Outcomes In Pneumonia Patients With Septic Shock, Acute Respiratory Distress Syndrome On Ecmo - Reuters
www.reuters.com - April 15 at 9:19 AM |
| New Study Suggests CytoSorb Improves Clinical Outcomes in Pneumonia Patients With Septic Shock and Acute Respiratory Distress Syndrome (ARDS) on ECMO
finance.yahoo.com - April 15 at 9:19 AM |
 | Stock Alert: CytoSorbents Up 30% On FDA's Approval To Use CytoSorb For COVID-19 - Nasdaq
www.nasdaq.com - April 13 at 3:15 PM |
| Blood purification device can stabilize coronavirus patients: CytoSorbents CEO - Yahoo Finance
finance.yahoo.com - April 13 at 3:15 PM |
 | CytoSorbents' stock jumps on FDA authorization for its device in COVID-19 patients - MarketWatch
www.marketwatch.com - April 13 at 3:15 PM |
| CytoSorbents: FDA Grants EUA Of CytoSorb In Patients With COVID-19 Infection - Nasdaq
www.nasdaq.com - April 13 at 9:11 AM |
| U.S. FDA Grants CytoSorb® Emergency Use Authorization for Use in Patients with COVID-19 Infection
finance.yahoo.com - April 13 at 9:11 AM |
| CytoSorbents' EBP device wins emergency OK to treat COVID-19 patients - Seeking Alpha
seekingalpha.com - April 11 at 1:51 PM |
| CytoSorbents CEO to Discuss COVID-19 Pandemic and its CytoSorb® Treatment of Cytokine Storm in Cowen COVID-19 Series Conference Call Today - Yahoo Finance
finance.yahoo.com - April 4 at 5:10 PM |
| CytoSorbents CEO to Discuss COVID-19 Pandemic and its CytoSorb® Treatment of Cytokine Storm in Cowen COVID-19 Series Conference Call Today - PRNewswire
www.prnewswire.com - April 3 at 5:24 PM |
| CytoSorbents CEO to Discuss COVID-19 Pandemic and its CytoSorb® Treatment of Cytokine Storm in Cowen COVID-19 Series Conference Call Today
finance.yahoo.com - April 3 at 5:24 PM |
